You will treat mets mostly with SBRT radiation. This is an approved treatment. You can repeat the radiation if cells show up at different areas in the body. So you do not radiate the same area twice:
I’m not real good with this stuff. (Reading studies).
This is standard of care? The reason I ask is, I’m wondering how common/prolific this practice is. At least where I live (E. TN) I could imagine RO’s being somewhat resistant to anything they’ve not been doing for the last 35 years.
Thanks for any thoughts or clarifications. (I noticed most of this work was done in Europe). It sounds promising.
Also, I know this may be a stupid question but, the reasoning for doing this is, “The longer ADT can be postponed, the better.”
(I ask this because, from my readings here, the concensus seems to be of late, “The earlier drugs are used, the better”. But, since the drugs are time limited, in my mind, fwiw, the longer one can keep that option
open would be better. Just tryin’ to figure this out.
Post Edited (island time) : 10/23/2019 1:57:07 AM (GMT-6)